SCHEMBL4033400

SCHEMBL4033400

CN1CCC(N2CCN(CCCOc3cc(OC4CCCC4)c4c(Nc5ccc(F)c(Cl)c5)ncnc4c3)CC2)CC1

nearest known ligand 0.78

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.78
SRC P12931 6/20 0.56
KDR P35968 5/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4212108 0.96 EGFR (0.72) EGFRSRCKDR
SCHEMBL4034208 0.94 EGFR (0.89) EGFRSRCKDR
SCHEMBL4034522 0.94 EGFR (0.74) EGFRSRCKDR
SCHEMBL4034424 0.92 EGFR (0.84) EGFRSRCKDR
SCHEMBL4037323 0.92 EGFR (0.89) EGFRSRCKDR
SCHEMBL4037082 0.91 EGFR (0.82) EGFRSRCKDR
SCHEMBL4039958 0.91 EGFR (0.82) EGFRSRCKDR
SCHEMBL4031574 0.91 EGFR (0.84) EGFRSRCKDR
SCHEMBL4032417 0.91 EGFR (0.81) EGFRSRCKDR
SCHEMBL4031704 0.91 EGFR (0.81) EGFRSRCKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444211-B1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2009-01-21 EP disclosed
CN-1764651-A Quinazoline derivatives as antitumor agents ASTRAZENECA AB (SE) 2006-04-26 CN disclosed